258 related articles for article (PubMed ID: 27530682)
1. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
2. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity.
Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD
J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
[TBL] [Abstract][Full Text] [Related]
5. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
6. Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA.
Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Biochem Biophys Res Commun; 2018 Nov; 506(3):703-708. PubMed ID: 30376989
[TBL] [Abstract][Full Text] [Related]
7. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
8. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
9. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
[TBL] [Abstract][Full Text] [Related]
10. Nuclear hyaluronidase 2 drives alternative splicing of
Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 EXON 11, a CERES (composite regulatory element of splicing) element involved in splice regulation.
Tammaro C; Raponi M; Wilson DI; Baralle D
Int J Mol Sci; 2014 Jul; 15(7):13045-59. PubMed ID: 25056543
[TBL] [Abstract][Full Text] [Related]
13. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
[TBL] [Abstract][Full Text] [Related]
15. SRSF9 Regulates Cassette Exon Splicing of Caspase-2 by Interacting with Its Downstream Exon.
Ha J; Jang H; Choi N; Oh J; Min C; Pradella D; Jung DW; Williams DR; Park D; Ghigna C; Zheng X; Shen H
Cells; 2021 Mar; 10(3):. PubMed ID: 33808656
[TBL] [Abstract][Full Text] [Related]
16. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.
Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ
J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190
[TBL] [Abstract][Full Text] [Related]
17. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
18. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
19. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
20. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
